Skip to main content

Table 2 Basal characteristics of the study participants at the time of spontaneous abortion

From: Screening for autoimmune thyroid disorders after spontaneous abortion is cost-saving and it improves the subsequent pregnancy rate

 

Treated with levothyroxine

Untreated

Controls

p-value

 

Before SpA

Newly after SpA

   

n

45

28

38

147

 

Age (years)

33

34

32

33

0.314

BMI

22.29

21.94

23.42

21.34

0.698

Family history of thyroid disease

19 (42%)

10 (36%)

14 (37%)

37 (25%)

0.118

Autoimmune pattern in TUS

10 (22%)

23 (82%)

30 (73%)

0 (0%)

<0.001

FT4 (pmol/l)

14.75 (11.70-22.20)

14.20 (11.30-20.60)

13.80 (11.00-17.50)

14.40 (11.10-20.20)

0.278

TSH (mIU/l)

1.84 (0.51-7.32)

2.26 (0.89-8.88)

1.91 (0.30-4.52)

1.54 (0.58-3.94)

0.002

TPOAb (kIU/l)

68.00 (15.00-4480.00)

118.00 (33.00-2820.00)

42.50 (22.00-1805.00)

41.00 (0.00-163.00)

<0.001

Subclinical hypothyroidism

-

8 (28%)

13 (34%)

-

0.827

Euthyroid AITD

-

20 (71%)

25 (66%)

-

0.827

  1. The values are expressed as median (range). SpA: spontaneous abortion; TUS: thyroid ultrasound; FT4, serum concentration of free thyroxin; TSH, serum concentration of thyroid stimulating hormone; TPOAb, serum concentration of antibodies to thyroid peroxidase; AITD, autoimmune thyroid disorders. ANOVA on ranks (except women with family history of thyroid disease and autoimmune pattern in TUS: Chi-square test).